Dr. Hadeer Ahmed Ahmed Aglan

Dr. Hadeer Ahmed Ahmed Aglan

Research Scientist
National Research Centre, Egypt


Highest Degree
Ph.D. in Biochemistry from Ain Shams University, Cairo, Egypt

Share this Profile

Biography

Dr. Hadeer Ahmed Ahmed Aglan is currently working as Researcher at National Research Centre, Egypt. She has completed her Ph.D. in Biochemistry from Ain Shams University, Cairo, Egypt. Her main area of interest focuses on Biomedical Sciences. Her area of expertise includes Biochemistry, Hormones, Stem Cells, Nanotechnology, and Natural Compounds. She has 4 publications in journals.

Area of Interest:

Biomedical Sciences
100%
Medical Biochemistry
62%
Hormones
90%
Stem Cells
75%
Nanotechnology
55%

Selected Publications

  1. Hamza, A.H., H.H. Ahmed and H.A. Aglan, 2019. An Overview on Alzheimer's Disease. Lambert Academic Publishing, Germany, ISBN-13: 978-613-9-45823-3, Pages: 76.
  2. Ahmed, H.H., H.A. Aglan, M. Mabrouk, A.A. Abd-Rabou and H.H. Beherei, 2019. Enhanced mesenchymal stem cell proliferation through complexation of selenium/titanium nanocomposites. J. Mater. Sci.: Mater. Med., Vol. 30, No. 2. 10.1007/s10856-019-6224-z.
    CrossRef  |  Direct Link  |  
  3. Aglan, H.A., H.H. Ahmed, N.S. Mahmoud, R.M. Aly, N.A. Ali and A.A. Abd-Rabou, 2019. Nanotechnological applications hold a pivotal position in boosting stem cells osteogenic activity: In vitro and in vivo studies. Applied Biochem. Biotechnol., (In Press). 10.1007/s12010-019-03105-y.
    CrossRef  |  Direct Link  |  
  4. Matloub, A.A., A.H. Salama, H.A. Aglan, M.M. AbouSamra, S.S.M. ElSouda and H.H. Ahmed, 2018. Exploiting bilosomes for delivering bioactive polysaccharide isolated from Enteromorpha intestinalis for hacking hepatocellular carcinoma. Drug Dev. Ind. Pharm., 44: 523-534.
    CrossRef  |  Direct Link  |  
  5. Aglan, H.A., M. Mabrouk, R.M. Aly, H.H. Beherei and H.H. Ahmed, 2018. Harnessing the antioxidant property of cerium andyttrium oxide nanoparticles to enhance mesenchymal stem cell proliferation. Asian J. Pharm. Clin. Res., 11: 436-442.
    Direct Link  |  
  6. Ahmed, H.H., M.D.A. El-Maksoud, A.E.A. Moneim and H.A. Aglan, 2017. Pre-clinical study for the antidiabetic potential of selenium nanoparticles. Biol. Trace Element Res., 177: 267-280.
    Direct Link  |  
  7. Aglan, H.A., H.H. Ahmed, S.A. El-Toumy and N.S. Mahmoud, 2017. Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study. Tumor Biol., Vol. 39. 1010428317699127.
    CrossRef  |  Direct Link  |  
  8. Salem, N.A., H.H. Ahmed, H.A. Aglan and S.A. ElShebiney, 2016. Nanofiber-expanded stem cells mitigate liver fibrosis: Experimental study. Tissue Cell, 48: 544-551.
    CrossRef  |  Direct Link  |  
  9. Salem, N.A., H.H. Ahmed, H.A. Aglan and S.A. ElShebiney, 2016. Multi-targeted therapy of hepatic fibrosis by adipose tissue derived mesenchymal stem cells. Int. J. Pharm. Clin. Res., 8: 640-648.
    Direct Link  |  
  10. Matloub, A.A., H.A. Aglan, S.S.M. ElSouda, A.S. Maghraby, M.E. Aboutabl and H.H. Ahmed, 2016. Influence of bioactive sulphated polysaccharide-protein complexes on hepatocarcinogenesis, angiogenesis and immunomodulatory activities. Asian Pac. J. Trop. Med., 10.1016/j.apjtm.2016.11.004.
    CrossRef  |  Direct Link  |  
  11. Matloub, A.A., H.A. Aglan, S.S.M. El Souda, M.E. Aboutabl, A.S. Maghraby and H.H. Ahmed, 2016. Influence of bioactive sulfated polysaccharide-protein complexes on hepatocarcinogenesis, angiogenesis and immunomodulatory activities. Asian Pac. J. Trop. Med., 9: 1200-1211.
    CrossRef  |  Direct Link  |  
  12. Ahmed, H.H., M.M. Fateheya, A.A. Hadeer and H.A. Sayed, 2016. Exploring potential mechanisms of action of mesenchymal stem cells in Parkinson's disease: In vivo study. Int. J. Curr. Pharm. Rev. Res., 7: 275-282.
  13. Ahmed, H.H., M.D.A. El-Maksoud, A.E.A. Moneim and H.A. Aglan, 2016. Pre-clinical study for the anti-diabetic potential of selenium nanoparticles. Biol. Trace Elem. Res., 10.1007/s12011-016-0876-z.
    CrossRef  |  Direct Link  |  
  14. Ahmed, H.H., H.A. Aglan, A.M. Zaazaa, A.B. Shalby and S.A. El Toumy, 2016. Quercetin confers tumoricidal activity through multipathway mechanisms in a n-methylnitrosourea rat model of colon cancer. Asian Pac. J. Cancer Prev., 17: 4991-4998.
    CrossRef  |  Direct Link  |  
  15. Ahmed, H.H., H.A. Aglan and A.A. Abd-Rabou, 2016. Stem Cells and Neurodegenerative Diseases. In: Developmental and Stem Cell Biology in Health and Disease, El-Hashash, A. (Ed.)., Bentham Science, USA., ISBN: 978-1-68108-220-2, pp: 165-191.
  16. Ahmed, H.H., E.R.A. Raouf, L.A. Rashed and H.A. Aglan, 2016. New approaches in the horizon for treatment of Alzheimer`s disease. Der Pharma. Lett., 8: 158-166.
  17. Ahmed, H.H., A.M. Salem, H.M. Atta, E.F. Eskandar and A.R.H. Farrag et al., 2016. Updates in the pathophysiological mechanisms of Parkinson`s disease: Emerging role of bone marrow mesenchymal stem cells. World J. Stem Cells, 8: 106-117.
    CrossRef  |  Direct Link  |  
  18. Ahmed, H.H., F.M. Metwally, W.K.B. Khalil and H.A. Aglan, 2015. Bone marrow derived mesenchymal stem cells: A unique cytotherapy for rescuing degenerated dopaminergic neurons. Neurochemical J., (In Press). .
  19. Ahmed, H.H., F.M. Metwally, W.K.B. Khalil and H.A. Aglan, 2015. Bone marrow derived mesenchymal stem Cells: A unique cytotherapy for rescuing degenerated dopaminergic neurons. Neurochem. J., 9: 284-294.
    CrossRef  |  Direct Link  |  
  20. Aglan, H., H. Ahmed and H. Atta, 2015. Cell Therapy in Neurodegenerative Diseases: Mesenchymal Stem Cells and Neurodegeneration. LAP Lambert Academic Publishing, Germany, ISBN: 978-3-659-39739-4, Pages: 428.
  21. Salem, A.M., H.H. Ahmed, H.M. Atta, M.A. Ghazy and H.A. Aglan, 2014. Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats. Cell Biol. Int., 38: 1367-1383.
    CrossRef  |  Direct Link  |  
  22. Ahmed, H.H., A.M. Salem, H.M. Atta, M.A. Ghazy and H.A. Aglan, 2014. Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model? Hum. Exp. Toxicol., 33: 1217-1231.
    CrossRef  |  Direct Link  |  
  23. Salem, A.M., G.M. Sabry, M.M. Abd-ElHalem and H.A. Aglan, 2009. Synthesis of estrogen derivatives with anti-osteoporosis activity. Egypt. Med. J. Natl. Res. Centre, 8: 25-39.